Potential applications include fibrosis treatment via ECM remodeling, metabolic syndrome intervention through g6pca.1 modulation, and neuro-immune communication tuning via protease-inhibitor balance (serpinf2a-prss1). Here, PRSS1 is linked to metabolic syndrome.